Altered actin cytoskeleton and inhibition of matrix metalloproteinase expression by vanadate and phenylarsine oxide, inhibitors of phosphotyrosine phosphatases: Modulation of migration and invasion of human malignant glioma cells
Sk. Chintala et al., Altered actin cytoskeleton and inhibition of matrix metalloproteinase expression by vanadate and phenylarsine oxide, inhibitors of phosphotyrosine phosphatases: Modulation of migration and invasion of human malignant glioma cells, MOL CARCINO, 26(4), 1999, pp. 274-285
Cell-matrix interactions exert a profound influence on cell function and be
havior. Our earlier observations suggested that disruption of the actin cyt
oskeleton results in the inhibition of phorbol ester-induced matrix metallo
proteinase (MMP)-9 expression. In this study, to understand the role of pro
tein tyrosine phosphatases in matrix metalloproteinase-9 expression, we tre
ated glioblastoma cells with vanadate and phenylarsine oxide (PAO), which a
re inhibitors of protein tyrosine phosphatases. Vanadate and PAO inhibited
expression of phorbol ester-induced MMP-9 as well as constitutive expressio
n of matrix metalloproteinase-2 in a dose- and time-dependent fashion. An a
ssay of the activity of phosphotyrosine phosphatase (PTPase) indicated that
vanadate-treated cells had reduced PTPase activity compared with that of u
ntreated controls. Vanadate and PAO also inhibited actin polymerization, ce
ll spreading, migration, and invasion of glioma cells. Furthermore, elevate
d levels of protein tyrosine phosphorylation were observed in vanadate- and
PAO-treated cells in both a concentration- and time-dependent fashion and
were seen to have an inverse correlation with focal adhesion kinase protein
expression. These results suggest that vanadate and PAO inhibited migratio
n and invasion of glioma cells by their effect on the cytoskeleton and inhi
bition of MMP expression. Mol. Carcinog. 26:274-285, 1999. (C) 1999 Wiley-L
iss, Inc.